Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by “rete ematologica pugliese”
Giuseppe Mele(Italian Society of Physiotherapy), Domenico Pastore(Istituto di Ematologia di Bologna), Nicola Di Renzo(Presidio Ospedaliero), Giuseppe Tarantini(University of Padua), Angela Maria Quinto(Platinum Group Coatings (United States)), Angelo Michele Carella(San Antonio College), Nicola Cascavilla, Candida Germano, Lorella Melillo(San Antonio College), Pellegrino Musto(University of Bari Aldo Moro), Giorgina Specchia(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Attilio Guarini(Istituto Tumori Bari), Anna Mele, Paola Curci(University of Bari Aldo Moro), Vincenzo Pavone, Nicola Sgherza(University of Bari Aldo Moro), Anna Pia Falcone(Ospedale Vito Fazzi), Gaetano Palumbo(Ospedali Riuniti di Foggia), Alessandro Spina(Ospedale A. Perrino), Patrizio Mazza(Ospedale SS. Annunziata), Bernardo Rossini(Istituto Tumori Bari), Giovanni Reddiconto(Istituto di Ematologia di Bologna), Giulia Palazzo(Azienda Ospedaliera S.Giuseppe Moscati), Francesca Merchionne(Ospedale A. Perrino)
Cited by 2
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644